Recent Price Movement and Market Context
India Glycols has experienced a downward trend over the past week, with the stock declining by 1.76%, significantly underperforming the Sensex which remained almost flat with a marginal 0.01% change. The month-to-date performance is more pronounced, with the stock falling 12.36%, compared to the Sensex’s modest 1.31% decline. Year-to-date, the stock has shed 8.11%, again underperforming the benchmark index’s 1.94% loss. This short-term weakness contrasts sharply with the company’s impressive longer-term returns, where it has outpaced the market substantially.
On 16-Jan, the stock opened sharply lower, down 5.94%, and touched an intraday low of ₹902.05, reflecting significant selling pressure early in the session. The weighted average price indicates that most trading volume occurred near this low, suggesting that sellers dominated the day. Additionally, the stock has been on a three-day losing streak, cumulatively falling 2.82% during this period. This pattern points to a phase of profit-taking or cautious sentiment among investors in the near term.
Investor participation has also waned, with delivery volumes on 14 Jan dropping by nearly 29% compared to the five-day average. This decline in investor engagement may be contributing to the stock’s inability to sustain higher levels despite its underlying strengths. However, liquidity remains adequate, supporting reasonable trade sizes without excessive price impact.
Handpicked from 50, scrutinized by experts – Our recent selection, this Mid Cap from Bank - Public, is already delivering results. Don't miss next month's pick!
- - Expert-scrutinized selection
- - Already delivering results
- - Monthly focused approach
Fundamental Strengths Supporting the Stock
Despite the recent price softness, India Glycols continues to demonstrate strong operational and financial metrics. The company has reported positive results for three consecutive quarters, with profit after tax (PAT) for the latest six months reaching ₹138.31 crores, marking a healthy growth rate of 25.63%. This earnings momentum underpins the stock’s attractive valuation.
Return on capital employed (ROCE) stands at a robust 11.46% for the half year, indicating efficient utilisation of capital. The company’s debtors turnover ratio is also notably high at 30.92 times, reflecting effective management of receivables and cash flow. These factors contribute to a favourable enterprise value to capital employed ratio of 1.9, suggesting that the stock is trading at a discount relative to its peers’ historical valuations.
Over the past year, India Glycols has delivered a remarkable 46.33% return to shareholders, significantly outperforming the broader market’s 8.47% gain. Profit growth of 33.6% over the same period further validates the company’s strong fundamentals. The PEG ratio of 1 indicates that the stock’s price growth is in line with its earnings growth, supporting a balanced valuation perspective.
Holding India Glycols from Commodity Chemicals? See if there's a smarter choice! SwitchER compares it with peers and suggests superior options across market caps and sectors!
- - Peer comparison ready
- - Superior options identified
- - Cross market-cap analysis
Technical Indicators and Investor Sentiment
From a technical standpoint, the stock remains above its 200-day moving average, signalling a positive long-term trend. However, it is trading below its 5-day, 20-day, 50-day, and 100-day moving averages, indicating short-term weakness and possible consolidation. This divergence suggests that while the stock’s fundamentals remain intact, investors are exercising caution amid recent volatility.
The combination of falling investor participation and the recent gap-down opening points to a temporary phase of profit-taking or risk aversion. Such corrections are not uncommon following strong rallies, especially when the stock has outperformed the market by a wide margin over the past year and several years prior.
In summary, the recent decline in India Glycols’ share price on 16-Jan reflects short-term selling pressure and reduced investor enthusiasm rather than a deterioration in the company’s core business performance. The stock’s attractive valuation, solid earnings growth, and market-beating returns continue to support a positive medium to long-term outlook, making it a hold-worthy investment despite the current pullback.
Get 2 full years of MojoOne Premium for only Rs. 12,999. Subscribe for 1 year and we'll add another year FREE. Offer valid for a limited time. Start Saving Now →
